Bio CND Inc (217950)

Currency in KRW
33,800
-200(-0.59%)
Delayed Data·
217950 Scorecard
Full Analysis
Suffers from weak gross profit margins
217950 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
33,00034,000
52 wk Range
26,70050,000
Key Statistics
Bid/Ask
33,350.00 / 33,800.00
Prev. Close
34,000
Open
34,000
Day's Range
33,000-34,000
52 wk Range
26,700-50,000
Volume
1.12K
Average Volume (3m)
2.54K
1-Year Change
-5.87%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
217950 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a poor free cash flow yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell

Bio CND Inc Company Profile

PharmaResearch BIO Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products worldwide. The company offers ReNTox injection for temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged between 18 and 65. It is also developing Clostridium Botulinum Toxin type A, which is in Phase I clinical study for indications, including dynamic equinus foot deformity, upper limb spasticity, blepharospasm, etc. The company was formerly known as BIOCND Inc. and changed its name to PharmaResearch BIO Co., Ltd. in March 2018. PharmaResearch BIO Co., Ltd. was founded in 2009 and is headquartered in Gangneung, South Korea.

Compare 217950 to Peers and Sector

Metrics to compare
217950
Peers
Sector
Relationship
P/E Ratio
0.0x4.1x−0.7x
PEG Ratio
0.000.000.00
Price/Book
0.0x1.2x2.6x
Price / LTM Sales
0.0x0.8x3.3x
Upside (Analyst Target)
0.0%0.0%39.6%
Fair Value Upside
Unlock7.3%6.0%Unlock

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

217950 Income Statement

FAQ

What Stock Exchange Does Bio CND Trade On?

Bio CND is listed and trades on the Korea New Exchange stock exchange.

What Is the Stock Symbol for Bio CND?

The stock symbol for Bio CND is "217950."

What Is the Bio CND Market Cap?

As of today, Bio CND market cap is 142.15B.

What Is Bio CND's Earnings Per Share (TTM)?

The Bio CND EPS (TTM) is 0.00.

From a Technical Analysis Perspective, Is 217950 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Bio CND Stock Split?

Bio CND has split 0 times.

How Many Employees Does Bio CND Have?

Bio CND has 0 employees.

What is the current trading status of Bio CND (217950)?

As of 15 Oct 2025, Bio CND (217950) is trading at a price of 33,800, with a previous close of 34,000.00. The stock has fluctuated within a day range of 33,000 to 34,000, while its 52-week range spans from 26,700 to 50,000.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.